In this issue:
Concurrent vs sequential SRS and ICI in MBM
MBM patterns of care and clinical outcomes
MBM that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab associated with IPRES
Seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma
AXL expression in primary cutaneous melanoma a predictor of sentinel node metastasis
c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma
Inhibition of PAI-1 blocks PD-L1 endocytosis and improves the response of melanoma cells to ICB
Survival outcomes of salvage metastasectomy after failure of modern-era systemic therapy for melanoma
Surveillance of sentinel node-positive melanoma patients who receive adjuvant therapy without CLND
Clinical outcome of metastatic MUP in the era of novel therapy
Neoadjuvant T-VEC + surgery vs surgery alone for resectable stage IIIB–IVM1a melanoma
T-VEC for advanced locoregional melanoma after failure of immunotherapy
Please login below to download this issue (PDF)